ANAVEX LIFE SCIENCES CORP (AVXL)
US0327973006 - Common Stock
| TTM (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -43.16M | -47.51M | -47.98M | -37.91M | -26.28M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -307.00K | 2.51M | 5.36M | -710.00K | 120.00K | |||
| Taxes Paid | 233.00K | 140.00K | 330.00K | N/A | N/A | |||
| Other non cash items | 14.15M | 17.22M | 18.38M | 8.23M | 4.88M | |||
| OPERATING CASH FLOW | -29.31M | -27.79M | -24.24M | -30.38M | -21.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 29.45M | 29.65M | 21.99M | 158.79M | 28.75M | |||
| Other Financing Activity | N/A | 0.00 | -710.00K | -5.55M | -400.00K | |||
| FINANCING CASH FLOW | 29.45M | 29.65M | 21.29M | 153.24M | 28.35M | |||
| Exchange Rate Effect | N/A | -40.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | 147.00K | 1.87M | -2.95M | 122.86M | 7.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.31M | -27.79M | -24.24M | -30.38M | -21.29M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -29.31M | -27.79M | -24.24M | -30.38M | -21.29M | |||
All data in USD